Evidence map›Paper›PMID 38628296›Full record

ArticleInternational journal of cardiology. Heart & vasculature2024

Impact of the number of modifiable risk factors on clinical outcomes after percutaneous coronary intervention: An analysis from the e-Ultimaster registry.

Ofer Kobo, Yaniv Levi, Rami Abu-Fanne, Clemens Von Birgelen, Antoine Guédès, Adel Aminian, Peep Laanmets, Willem Dewilde, Adam Witkowski, Jacques Monsegu and 4 more

Abstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Recent highlights from theInternational journal of cardiology. Heart & vasculature · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. The hasty generalization fallacy: not all coronary artery disease is the same.International journal of cardiology. Heart & vasculature · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ofer KoboHillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.
Yaniv LeviHillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.
Rami Abu-FanneHillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.
Clemens Von BirgelenThoraxcentrum Twente, Medisch Spectrum Twente, and Department Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
Antoine GuédèsCHU UCL Namur, Site de Mont Godinne, Université catholique de Louvain, Belgium.
Adel AminianCentre Hospitalier Universitaire de Charleroi, Charleroi, Belgium.
Peep LaanmetsNorth Estonia Medical Center Foundation, Tallinn, Estonia.
Willem DewildeImelda Hospital, Bonheiden, Belgium.
Adam WitkowskiInstitute of Cardiology, Warsaw, Poland.
Jacques MonseguInstitut Cardio-Vasculaire, Groupe Hospitalier Mutualiste, Grenoble, France.
Andres Romo IniguezHospital Álvaro Cunqueiro, Vigo, Spain.
Majdi HalabiZiv Medical Center, Zfat, Israel.
Mamas A MamasKeele Cardiovascular Research Group, Centre for Prognosis Research, Institutes of Applied Clinical Science and Primary Care and Health Sciences, Keele University, Keele, Newcastle, United Kingdom.
Ariel RoguinHillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: A substantial proportion of the patients undergoing percutaneous coronary intervention (PCI) have none of the of standard modifiable cardiovascular risk factors (SMuRFs): hypertension, diabetes, hypercholesterolaemia and smoking. The aim of this analysis was to compare clinical outcomes after PCI according to the number of SMuRFs. Methods: Patients with an indication for a PCI were stratified based upon the number of SMuRFs: 0, 1, 2 or 3-4. The primary outcome was target lesion failure (TLF), a composite of cardiac death, target vessel-related myocardial infarction or clinically driven target lesion revascularization at 1-year. Inverse weighted propensity score (IWPS) adjustment was performed to adjust for differences in baseline characteristics. Results: The prevalence of SMuRFs was: 0 SMuRF 16.4 %; 1 SMuRF 27.8 %; 2 SMuRFs 34.7 % and 3-4 SMuRFs 21.1 %. Patients without SMuRFs were younger, more likely to be male and had less complex coronary artery disease. The incidence of TLF increased with the number of SMuRFs: 2.65 %, 2.75 %, 3.23 %, and 4.24 %, P Conclusion: The incidence of clinical events at 1-year increased with the number of SMuRFs. While patients without SMuRFs have a relatively favourable risk profile, more research is needed to optimize therapeutic management in the majority of patients.

Indexed as

Clinical trialDrug eluting stentHumanPercutaneous coronary interventionRisk factor

Identifiers

PMID38628296
PMCPMC11018637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.